Well, I happen to believe Quest will have something out on the market before Sirna/Merck. That being said, I see no reason that S/M would not go forward with this.
Every year Merck is losing money as their patents expire and generics can be made from these once lucrative pills. For every pill they lose to patent expiration, they need to have many more possibilities in the pipeline.
I highly doubt Merck is afraid of being sued. They are in the business to make money. Vioxx was a bump for them. Many of the class action suits are about to be thrown out. For every bump there is a Gardasil or Januvia.
It's not to say there won't be problems with this. Clinical trials haven't even started yet so we don't know how well this will work.
Dee, I'm not sure what you mean by "If they discover how to turn off cancer cells, then and only then, may hair removal not be far behind." Sirna has been working on a number of possible treatments including those targeting macular degeneration, huntington's disease, asthma and cancer to name a few. This is NOT turning cells off. It is merely the suppression of messenger RNA. Destruction of mRNA prevents protein synthesis. In hair removal this in turn causes disruption of hair follicle integrity.
They know how RNAi technology works. It is the delivery that is the tricky part. With hair removal though, the delivery is pretty simple. They are getting better at delivery with many treatments though. MD trials showed marked improvements in patients sight. Hep C primate studies showed 99% virus load suppression.
One other note. Merck has done some work in this area. They are the makers of Propecia.
Edited by jme1 (04/14/07 12:45 AM)